Selegiline and excess mortality.
Oakes
D
D
D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy / Q000401:mortality*; D012642:Selegiline / Q000009:adverse effects* / Q000627:therapeutic use
D000978:Antiparkinson Agents; D004338:Drug Combinations; D012642:Selegiline; D007980:Levodopa